Akebia Therapeutics, Inc.

Direct answer

Akebia Therapeutics, Inc. is publicly traded on NASDAQ under the ticker AKBA.

Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering from kidney diseases. The firm's leading experimental drug, vadadustat, is an oral treatment currently in Phase III clinical trials. Its purpose is to address anemia resulting from chronic kidney disease (CKD) in adult...

Can you invest in Akebia Therapeutics, Inc.?

Yes. Akebia Therapeutics, Inc. trades publicly on NASDAQ as AKBA.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Akebia Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.